Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

World Health Organization (WHO)

New Jersey Department of Health Joins in World Hepatitis Day July 28

Trenton, NJ, July 28, 2017 — In recognition of World Hepatitis Day, the New Jersey Department of Health is joining the World Health Alliance (WHA) and the World Health Organization (WHO) to raise awareness about the global burden of viral hepatitis.

Viral hepatitis is inflammation of the liver caused by a virus. The most common types are hepatitis A, B and C — three different contagious liver infections caused by unrelated viruses.

Hepatitis A typically occurs in an “acute” or time-limited form, while hepatitis B and C can develop into a life-long, chronic illness. Continue reading

WHO Clinical Trial Finds New Ebola Vaccine Gives 100 Percent Protec

red-cross-ebolaWashington, DC, December 26, 2016 — Donald G. McNeil Jr. reports that, in a scientific triumph that will change the way the world fights a terrifying killer, an experimental Ebola vaccine tested on humans in the waning days of the West African epidemic has been shown to provide 100 percent protection against the lethal disease.

The vaccine has not yet been approved by any regulatory authority, but it is considered so effective that an emergency stockpile of 300,000 doses has already been created for use should an outbreak flare up again.

Since Ebola was discovered in the former Zaire in 1976, there have been many efforts to create a vaccine. Continue reading

Growing Antibiotic Resistance Forces WHO to Update Recommended Treatment for Sexually Transmitted Diseases

WHOGeneva, Switzerland, August 31, 2016 — New guidelines for the treatment of three common sexually transmitted infections (STIs) have been issued by the World Health Organization (WHO) in response to the growing threat of antibiotic resistance.

Chlamydia, gonorrhea and syphilis are all caused by bacteria and are generally curable with antibiotics. However, these STIs often go undiagnosed and are becoming more difficult to treat, with some antibiotics now failing as a result of misuse and overuse.

It is estimated that, each year, 131 million people are infected with chlamydia, 78 million with gonorrhea, and 5.6 million with syphilis. Continue reading

Michael Bloomberg Becomes WHO Global Ambassador for Noncommunicable Diseases

Michael Bloomberg

The Honorable Michael Bloomberg

Geneva, Switzerland, DC, August 18, 2016 — The World Health Organization (WHO) yesterday named Michael R. Bloomberg, philanthropist and former three-term Mayor of the City of New York, as Global Ambassador for Noncommunicable Diseases (NCDs).

NCD—including heart disease, stroke, cancer, diabetes and chronic respiratory diseases—and injuries are responsible for 43 million deaths each year, almost 80% of all deaths worldwide.

Each year, 16 million people die from NCDs before the age of 70.   Continue reading

World Health Organization: Life Expectancy Increased by 5 Years Since 2000, But Health Inequalities Persist

Hands baby oldGeneva, Switzerland, May 23, 2016 ― Dramatic gains in life expectancy have been made globally since 2000, but major inequalities persist within and among countries, according to this year’s “World Health Statistics: Monitoring Health for the SDGs”.

Life expectancy increased by 5 years between 2000 and 2015, the fastest increase since the 1960s.  Those gains reverse declines during the 1990s, when life expectancy fell in Africa because of the AIDS epidemic and in Eastern Europe following the collapse of the Soviet Union.

The increase was greatest in the African Region of WHO where life expectancy increased by 9.4 years to 60 years, driven mainly by improvements in child survival, progress in malaria control and expanded access to antiretrovirals for treatment of HIV. Continue reading

CDC Says in Full Outbreak Mode in Response to Zika

Zika mosquitoAtlanta, GA, January 30, 2016The New York Times reports that U.S. disease detectives have moved into full outbreak mode over the Zika virus, assembling a team of hundreds of experts to try to better understand its impact as it spreads in the Americas.

On Sunday, the U.S. Centers for Disease Control and Prevention dedicated an emergency operations center staffed around the clock to address Zika, a mosquito-borne virus linked to severe birth defects in thousands of babies in Brazil, agency officials told Reuters. Continue reading